Business
AstraZeneca unveils antibody treatment, preventative shot for those who can’t get vaccinated – The Sydney Morning Herald
The company said its drug offered hope to those who can’t receive COVID-19 vaccines, such as cancer patients, organ transplant…
The full results will be submitted for publication in a peer-reviewed medical journal.
Pascal Soriot, CEO of AstraZeneca, said the data showed the drug offered protection for six months and could last for 12 months, but the company needed a further six…
Continue Reading
